Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...

How Is a CSF Glucose Test Done? The most common way to check the glucose in your cerebrospinal fluid is by performing a lumbar puncture, also called a spinal tap. In some cases, your doctor can also ...

IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma. Background: Cerebrospinal ...

Testing cytokine levels in cerebrospinal fluid (CSF) may rapidly differentiate brain infections from other central nervous system (CNS) diseases, new research suggests. "We have many tests for making ...

A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers ...

Despite extensive use of biomarkers in research studies, most Alzheimer’s disease diagnoses in the United States are determined by clinical examination. That may be about to change. The Food and Drug ...

A team of researchers from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College used genetic testing of cells found in cerebrospinal fluid to track certain brain tumors. In their ...

Brain fluid started leaking from a woman's nose after she was swabbed for COVID-19 testing as the extra-long Q-tips caused 'trauma' to pre-existing defect in the woman's skull. The University of Iowa ...

A test that looks for genetic hallmarks of brain cancers in samples of cerebrospinal fluid can decrease the time to diagnosis and eliminate the need for invasive brain biopsies for some patients.

Summit (TM) 2.0 is a CSF-based liquid biopsy assay designed to enable comprehensive genomic profiling for characterization of CNS tumors. CNS malignancies present unique diagnostic challenges, as ...